Health Plan News logo
March 14th 2007
Tags: A&D Medical, Frost & Sullivan

No Comments

Frost & Sullivan Recognizes A&D Medical’s Technological Excellence in Advanced Blood Pressure Monitoring Solutions

Frost & Sullivan has selected A&D Medical / LifeSource as the recipient of the 2007 Excellence in Technology of the Year Award in the North American blood pressure monitoring market. A&D has developed advanced, innovative blood pressure monitoring solutions such as the AM/PM TimeWise(TM) tracking technology and the Pressure Rating Indicator(TM) ...
March 14th 2007
Tags: Aesculap Academy, Frost & Sullivan

No Comments

Frost & Sullivan Recognizes Aesculap Academy for Efforts to Offer Premium Medical Education

Frost & Sullivan has selected Aesculap Academy as the recipient of the 2007 Frost & Sullivan Global Medical Professional Education Institution of the Year Award. Aesculap Academy is the only professional education institute with presence in every major continent and courses in nearly every medical specialty. In 2005, in the 10th ...
March 14th 2007
Tags: Frost & Sullivan, Raytel Cardiac Services

No Comments

Frost & Sullivan Recognizes Raytel’s Essential Contribution to Remote Monitoring in Cardiac Rhythm Diseases

Frost & Sullivan selected Raytel Cardiac Services as the recipient of the 2007 U.S. Cardiovascular Enabling Technology of the Year Award for its dedicated efforts in the remote home reporting market for cardiac rhythm technologies. With the historic rise in chronic cardiac rhythm diseases, rising patient demand is poised to create ...



  • Alexion Pharmaceuticals Blue Cross and Blue Shield Blue Cross and Blue Shield of Minnesota case management Case Management Society of America Children's Hospital of Philadelphia cholesterol meter cholesterol test Cholesterol Test Meter CyberKnife diabetes diet dieting diets Environmental Tectonics Corporation Fairview clinic Healthcare Research HealthSouth high omega-3 diet LAP BAND Surgery Lidocaine Long-Term Care Malaria Vaccine Mannatech Medicaid Medical Search Medicare Advantage Omega-3 Pharmaceutical Cannabinoid Products Senior Living
  • Quote Compare Apply
    • March 11th 2010
    Tags: Healthcare Plan News Comments Off

    Blue Cross Blue Shield of Michigan Foundation Wins Big at 2010 Wilmer Shields Rich Awards Program

    The Blue Cross Blue Shield of Michigan Foundation earned two national awards for Excellence in Communications, one gold and one silver, in the 2010 Wilmer Shields Rich Awards Program. The awards, given by the Council on Foundations and the Communications Network, recognize important communication efforts that increase public awareness of ...
    March 2nd 2010
    Tags: Healthcare Plan News Comments Off

    HealthPass Now Offering UnitedHealthcare’s Oxford Health Benefit Plans

    HealthPass, a partnership between New York City, the New York Business Group on Health, and the health insurance industry, is now offering five of UnitedHealthcare's Oxford health insurance plans to employers. To qualify, the employers must have two to 50 eligible employees and be based in New York City or ...
    March 2nd 2010
    Tags: Healthcare Plan News Comments Off

    Verizon Wireless’ Mobile Healthcare Solutions Let Hospitals and Clinics Streamline Communications and Access Critical Data

    BASKING RIDGE, N.J., and ATLANTA, March 2 /PRNewswire/ -- Healthcare organizations ranging from large city hospitals to rural community health clinics can count on Verizon Wireless to deliver customized wireless solutions that allow caregivers the ability to utilize resources that enhance the patient experience. Representatives from Verizon Wireless, operator of ...
    March 2nd 2010
    Tags: Healthcare Plan News Comments Off

    Enanta Nominates EDP-239 as Lead Development Candidate for NS5A HCV Inhibitor Program

    WATERTOWN, Mass., March 2 /PRNewswire/ -- Enanta Pharmaceuticals, Inc. announced today the nomination of lead development candidate, EDP-239, from its NS5A hepatitis C virus (HCV) inhibitor program. EDP-239 has demonstrated picomolar potency against multiple genotypes of the virus and a preclinical pharmacokinetic profile amenable to once-a-day dosing. "Our NS5A inhibitor program ...
    March 2nd 2010
    Tags: Healthcare Plan News Comments Off

    Abbott and Enanta Announce Advancement of Hepatitis C Collaboration

    ABBOTT PARK, Ill. and WATERTOWN, Mass., March 2 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) and Enanta Pharmaceuticals announced today the advancement of their Hepatitis C (HCV) collaboration into Phase 2 clinical trials. The trial will evaluate three HCV antiviral agents, including the investigational protease inhibitor ABT-450, part of the Abbott-Enanta collaboration, and ...

    Search

    The archives run deep. Feel free to search older content using topic keywords.

    Browse by Category